Percutaneous transluminal coronary angioplasty: current status and future trends

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Technology

Background:

• Percutaneous transluminal coronary angioplasty (PTCA) was initially limited to patients with preserved left ventricular function and single-vessel coronary disease.
• The scope of PTCA patient selection has expanded considerably with accumulated clinical experience.

Purpose of the Study:

• To evaluate the evolving indications and outcomes of percutaneous transluminal coronary angioplasty (PTCA).
• To assess the impact of technological advancements on PTCA efficacy and safety.

Main Methods:

• Review of patient selection criteria evolution for PTCA.
• Analysis of the influence of technological innovations, such as steerable guidewires, on PTCA procedures.
• Assessment of complication rates and success rates in relation to procedural complexity.

Main Results:

• PTCA is now indicated for patients with multivessel coronary disease, coronary occlusions, and myocardial infarction.
• Technological improvements have enhanced the ability to treat complex and tortuous vessel lesions.
• Success rates for PTCA have substantially improved.
• The incidence of complications like coronary dissection, occlusion, and infarction has decreased despite increased case complexity.

Conclusions:

• Patient selection criteria for PTCA have broadened significantly.
• Technological advancements have made PTCA a safer and more effective treatment for a wider range of coronary artery disease patients.
• PTCA outcomes have improved, with higher success rates and lower complication rates even in complex cases.